|
rs3892097
|
CYP2D6
*4
|
Major enzyme for metabolizing ~25% of medications including opioids, antidepr...
|
Pharmacogenomics
|
|
Established
|
|
rs1065852
|
CYP2D6
*10
|
Decreased function CYP2D6 variant common in Asian populations
|
Pharmacogenomics
|
|
Established
|
|
rs4244285
|
CYP2C19
*2
|
No-function CYP2C19 variant affecting PPIs, clopidogrel, and some antidepress...
|
Pharmacogenomics
|
|
Established
|
|
rs12248560
|
CYP2C19
*17
|
Increased function CYP2C19 variant - rapid/ultrarapid metabolizer
|
Pharmacogenomics
|
|
Established
|
|
rs1360780
|
FKBP5
Intronic C>T
|
Co-chaperone of the glucocorticoid receptor that regulates cortisol feedback ...
|
Brain & Mental Health
|
|
Strong
|
|
rs6311
|
HTR2A
-1438G>A
|
Regulatory variant in serotonin 2A receptor gene affecting SSRI side effects ...
|
Brain & Mental Health
|
|
Moderate
|
|
rs16947
|
CYP2D6
*2
|
Common CYP2D6 variant defining the *2 allele; previously considered normal-fu...
|
Pharmacogenomics
|
|
Strong
|
|
rs25531
|
SLC6A4
A>G
|
Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and...
|
Brain & Mental Health
|
|
Moderate
|
|
rs5030655
|
CYP2D6
*6
|
Frameshift deletion causing no enzyme function, defining poor metabolizer sta...
|
Pharmacogenomics
|
|
Established
|
|
rs28371725
|
CYP2D6
*41
|
Intronic splice variant causing decreased CYP2D6 enzyme activity through aber...
|
Pharmacogenomics
|
|
Established
|
|
rs3745274
|
CYP2B6
516G>T
|
Decreased-function variant affecting metabolism of efavirenz, methadone, bupr...
|
Pharmacogenomics
|
|
Established
|
|
rs5443
|
GNB3
C825T
|
Synonymous exon-10 variant that triggers alternative splicing of the G-protei...
|
Hormones & Sleep
|
|
Strong
|
|
rs35599367
|
CYP3A4
*22
|
Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin...
|
Pharmacogenomics
|
|
Established
|